Kala Bio KALA
NASDAQ KALA
$0.42 -0.01 (-3.21%)
As of: Oct 1, 2026 · 3:18 PM EDT

Kala Bio (KALA) Finished Goods (2018 - 2019)

Updated

Kala Bio (KALA) recorded Finished Goods of $585,000 in Q2 2019, down 12.9% from the prior quarter.

Analysis

Kala Bio (KALA) Finished Goods (2018 - 2019) Analysis & Trends

At the end of FY2018, Kala Bio reported Finished Goods of $388,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Kala Bio 6.57 Mn 6.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 585,000.00
Mar 31, 2019 672,000.00
Dec 31, 2018 388,000.00
API Access

Kala Bio Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=KALA&period=max&api_key=YOUR_API_KEY